Skip to main content
. 2022 Jul 21;4(11):100544. doi: 10.1016/j.jhepr.2022.100544

Fig. 3.

Fig. 3

Changes in PBC-40 QoL scores (PD analysis set).

Median (90% CI) change from baseline in (A) itch, (B) symptom, (C) fatigue, (D) cognitive, (E) emotional well-being, and (F) social/family well-being scores on Days 28, 56, and 84. ∗p <0.05 compared with placebo. PD, pharmacodynamic; QoL, quality of life.